Case File
efta-efta00903250DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00903250
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: "Moths, Paul V"
Subject: Re:
Date: Wed, 02 Feb 2011 11:40:32 +0000
anyone internally?
On Tue, Feb 1, 2011 at 9:53 PM, Morris, Paul V <
% wrote:
I'll grab tin tomorrow if he's around and call you, I don't think tm has spent much time on 881 and he thought perhaps an
international tax specialist might be a better source.
From: Jeffrey Epstein <[email protected]>
To: Morris, Paul V
Sent: Tue Feb 01 21:40:16 2011
Subject: Re:
I would like to speak to tm, it will be faster.
On Tue, Feb 1, 2011 at 6:47 PM, Moths, Paul V <
> wrote:
Jeffrey, I spoke with TM, is it possible to give us a little more context of the 881 issue, is this connected to the PPF
structure. Just want to make sure we research this properly and if we can't be helpful get you to right person.
From: Jeffrey Epstein [mailto:jeevaeationtil
ail com
Sent: Monday, January 31, 2011 2:00 PM
'11): Morris, Paul V
Subject:
coudl you ask tom if he as more insight into the 881„ satisfying obliogations to non resident shareholders
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal
EFTA00903250
I privilege, and legal entity disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal
privilege, and legal entity disclaimers, available at http://www.jpmorgan.cotn/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00903251
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]URL
http://www.jpmorgan.com/pages/disclosures/emailURL
http://www.jpmorgan.cotn/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.